Skip to main content

Myeloproliferative Disorders News

FDA Approves Jakafi to Treat Myelofibrosis

November 16, 2011 – The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Multiple Myeloma, Blood Disorders